Highest-materiality recent filing
Encompass Health enters $1B revolver with Truist; matures 2031, replaces 2022 facility
New $1.0B revolving credit facility with Truist Bank as administrative agent; maturity extended to March 9, 2031 (from Oct 2027).
Encompass Health Reports Q4 and Full Year 2025 Financial Results
Press release dated February 5, 2026, covers three months and year ended December 31, 2025.
Encompass Health appoints Patrick Tuer as EVP/COO; Q1 earnings filed without specific figures
Patrick Tuer (41) named EVP & COO effective April 24, 2025; previously Group President overseeing 69 hospitals.
Encompass Health reaffirms 5-year growth targets; RCD affirmation >95% in Alabama
Five-year targets (2023-27): 6-10 de novos/year, 80-120 bed additions/year, 6-8% discharge CAGR.
Encompass Health completes spin-off of home health/hospice business into Enhabit
Distribution effective July 1, 2022; one Enhabit share for every two EHC shares held on June 24, 2022.
Form 10 for Enhabit, Inc. became effective June 17, 2022; final information statement issued June 21.
On April 24, 2025, Encompass Health issued a press release announcing the appointment of Patrick W. Tuer as Executive Vice President and Chief Operating Officer
the appointment of Edward M. Christie III as director to fill the newly created vacant seat.
the appointment of Kevin J. O’Connor as director
the appointment of Christopher R. Reidy as director.
On August 31, 2021, the Board of Directors (the “Board”) of Encompass Health Corporation (the “Corporation”), unanimously approved, effective as of October 1, 2021, an increase in the number of directors constituting the Board of the Corporation from 14 to 15 and, upon the recommendation of its Nominating/Corporate Governance Committee, the appointment of Christopher R. Reidy as director to fill the newly created vacant seat.
Max materiality 0.80 · Median 0.35 · Most common event other_material